+7 (701) 759 90 19
USD 414.77 EUR 506.81
RUB 5.64 CNY 64.32
News

Less than half of S. Koreans willing to receive COVID-19 vaccine shots immediately: poll

22 February 2021 17:45
Share in:
Less than half of S. Koreans willing to receive COVID-19 vaccine shots immediately: poll

SEOUL. KAZINFORM - Less than half of South Koreans are willing to receive COVID-19 vaccine shots immediately, without waiting for further reports on those vaccines' effects, an opinion poll showed Monday, Yonhap reports.

Related news
Pfizer-BioNTech studying COVID-19 jab booster shot S. Korea: Vaccine distribution on roll for 1st shots on Friday Roundup: U.S. launches new initiative to study "Long COVID"

In the survey conducted on 1,020 people aged 18 or over by the Korea Society Opinion Institute from last Friday to Saturday, only 45.8 percent said they are willing to be vaccinated «right away» when their turn for COVID-19 vaccine shots comes.

Another 45.7 percent responded they will delay their vaccinations to «watch the situation» regarding the vaccines' effects, while 5.1 percent said they will refuse vaccine shots entirely, according to the poll result. The remaining 3.4 percent said they are not sure.

The survey also showed that 55.8 percent of the respondents have confidence in the government's handling of the national vaccination program, while 41.1 percent have distrust.

The survey, commissioned by radio broadcaster TBS, has a 95 percent confidence level with a margin of error of plus or minus 3.1 percentage points.

The survey result came as the country is set to kick off a nationwide vaccination program on Friday, starting with staff members and patients aged below 65 at infection-prone nursing homes, rehabilitation facilities and sanatoriums across the country.

But public concerns are still lingering over the safety and efficacy of COVID-19 vaccines, especially after the government postponed the use of AstraZeneca's vaccine, one of the vaccines South Korea has opted for, for people aged 65 or older, pending further clinical trial results.



Share in:
+7
Send
Employees online
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048
Editor
Seilkhanov Adlet
Seilkhanov Adlet
954-048

Archive